A part of the DNA sequence of the BRCA1 breast cancer gene (Table 1, target) was chosen as the target in this work, because it has been reported that the replacement of guanine (G) with thymine (T) in this gene (Table 1, mutant) is linked to familial breast and ovarian cancers [46,47]. The gene discussed is BRCA1; the disease is ovarian carcinoma.